Modified mRNA-LNP Vaccines Confer Protection against Experimental DENV-2 Infection in Mice

The global distribution and burden of dengue

Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G., Sankoh, O., et al. (2013) · Nature · doi:10.1038/nature12060 · Cited by 10,037 · see citing works

mRNA vaccines — a new era in vaccinology

Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667 · see citing works

mRNA-based therapeutics--developing a new class of drugs

Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474 · see citing works

Dengue: a continuing global threat

Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., et al. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2460 · Cited by 2,082 · see citing works

Dengue

Simmons, C. P., Farrar, J., Châu, N. V. V., & Wills, B. A. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1110265 · Cited by 1,736 · see citing works

Structure of Dengue Virus

Kuhn, R. J., Zhang, W., Rossmann, M. G., Pletnev, S. V., Corver, J., Lenches, E. M., Jones, C. T., Mukhopadhyay, S., Chipman, P. R., Strauss, E. G., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00660-8 · Cited by 1,565 · see citing works

Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America

Villar, L. A., Dayan, G. H., Arredondo-Garcı́a, J. L., Rivera, D. M., da Cunha, R. V., Deseda, C. C., Reynales, H., da Costa, M. S. N., Morales-Ramirez, J. O., Carrasquilla, G., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1411037 · Cited by 943 · see citing works

Modified mRNA vaccines protect against zika virus infection

Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909 · see citing works

Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

Pardi, N., Hogan, M. J., Pelc, R. S., Muramatsu, H., Andersen, H., DeMaso, C. R., Dowd, K. A., Sutherland, L. L., Scearce, R. M., Parks, R., et al. (2017) · Nature · doi:10.1038/nature21428 · Cited by 884 · see citing works

Molecular biology of flaviviruses

Lindenbach, B. D., & Rice, C. M. (2003) · Advances in virus research · doi:10.1016/s0065-3527(03)59002-9 · Cited by 857 · see citing works

Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody

Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 811 · see citing works

Dengue

Wilder‐Smith, A., Ooi, E. E., Horstick, O., & Wills, B. A. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32560-1 · Cited by 727 · see citing works

Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses

Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, Ö., Thompson, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.035 · Cited by 642 · see citing works

Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics

Maier, M. A., Jayaraman, M., Matsuda, S., Liu, J., Barros, S., Querbes, W., Tam, Y. K., Ansell, S. M., Kumar, V., Qin, J., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.124 · Cited by 625 · see citing works

Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination

Beatty, P. R., Puerta-Guardo, H. N., Killingbeck, S. S., Glasner, D. R., Hopkins, K. C., & Harris, E. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa3787 · Cited by 511 · see citing works

Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses

Vogel, A. B., Lambert, L., Kinnear, E., Busse, D., Erbar, S., Reuter, K. C., Wicke, L., Perkovic, M., Beissert, T., Haas, H., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.017 · Cited by 501 · see citing works

Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered.

Halstead, S. B., Nimmannitya, S., & Cohen, S. N. (1970) · PubMed · Cited by 480 · see citing works

Immunolocalization of the Dengue Virus Nonstructural Glycoprotein NS1 Suggests a Role in Viral RNA Replication

Mackenzie, J. M., Jones, M. K., & Young, P. R. (1996) · Virology · doi:10.1006/viro.1996.0307 · Cited by 457 · see citing works

Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

Biswal, S., Reynales, H., Sáez‐Llorens, X., López, P., Borja-Tabora, C., Kosalaraksa, P., Sirivichayakul, C., Watanaveeradej, V., Rivera, L., Espinoza, F., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1903869 · Cited by 415 · see citing works

Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination

Desmet, C. J., & Ishii, K. J. (2012) · Nature reviews. Immunology · doi:10.1038/nri3247 · Cited by 390 · see citing works

From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine

Guy, B., Barrere, B., Malinowski, C., Saville, M. K., Teyssou, R., & Lang, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.094 · Cited by 323 · see citing works

Nucleoside-modified mRNA immunization elicits influenza virus hemagglutinin stalk-specific antibodies

Pardi, N., Parkhouse, K., Kirkpatrick, E., McMahon, M., Zost, S. J., Mui, B. L., Tam, Y. K., Karikó, K., Barbosa, C. J., Madden, T. D., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05482-0 · Cited by 281 · see citing works

Folding and Dimerization of Tick-Borne Encephalitis Virus Envelope Proteins prM and E in the Endoplasmic Reticulum

Lorenz, I. C., Allison, S. L., Heinz, F. X., et al. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5480-5491.2002 · Cited by 261 · see citing works

Antibodies against West Nile Virus Nonstructural Protein NS1 Prevent Lethal Infection through Fc γ Receptor-Dependent and -Independent Mechanisms

Chung, K. M., Nybakken, G. E., Thompson, B. S., et al. (2006) · Journal of Virology · doi:10.1128/jvi.80.3.1340-1351.2006 · Cited by 241 · see citing works

The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis

Glasner, D. R., Puerta-Guardo, H. N., Beatty, P. R., & Harris, E. (2018) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-041848 · Cited by 228 · see citing works

Flavivirus NS1 protein in infected host sera enhances viral acquisition by mosquitoes

Liu, J., Liu, Y., Nie, K., Du, S., Qiu, J., Pang, X., Wang, P., & Cheng, G. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.87 · Cited by 196 · see citing works

Adjuvant effects of a sequence-engineered mRNA vaccine: translational profiling demonstrates similar human and murine innate response

Edwards, D. K., Jasny, E., Yoon, H., Horscroft, N., Schanen, B., Geter, T., Fotin-Mleczek, M., Petsch, B., & Wittman, V. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-016-1111-6 · Cited by 186 · see citing works

Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease

Meyer, M., Huang, E., Yuzhakov, O., Ramanathan, P., Ciaramella, G., & Bukreyev, A. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix592 · Cited by 178 · see citing works

Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment

Beatty, M. E., Beutels, P., Meltzer, M. I., Shepard, D. S., Hombach, J., Hutubessy, R. C. W., Dessis, D., Coudeville, L., Dervaux, B., Wichmann, O., et al. (2011) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.10-0521 · Cited by 171 · see citing works

Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine

Wilder‐Smith, A., Hombach, J., Ferguson, N. M., Selgelid, M. J., O’Brien, K. L., Vannice, K., Barrett, A. D. T., Ferdinand, E., Flasche, S., Guzmán, M. G., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30494-8 · Cited by 169 · see citing works

Dengue fever

Kularatne, S. A. M. (2015) · BMJ · doi:10.1136/bmj.h4661 · Cited by 155 · see citing works

The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease

Coller, B.-A., Clements, D. E., Bett, A. J., Sagar, S. L., & ter Meulen, J. H. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.021 · Cited by 142 · see citing works

Antibody Recognition of Cell Surface-Associated NS1 Triggers Fc-γ Receptor-Mediated Phagocytosis and Clearance of West Nile Virus-Infected Cells

Chung, K. M., Thompson, B. S., Fremont, D. H., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00879-07 · Cited by 139 · see citing works

Nucleoside modified mRNA vaccines for infectious diseases

Pardi, N., & Weissman, D. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6481-9_6 · Cited by 129 · see citing works

Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques

Pardi, N., LaBranche, C. C., Ferrari, G., Cain, D. W., Tombácz, I., Parks, R. J., Muramatsu, H., Mui, B. L., Tam, Y. K., Karikó, K., et al. (2019) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2019.03.003 · Cited by 103 · see citing works

Antibodies Against Modified NS1 Wing Domain Peptide Protect Against Dengue Virus Infection

Lai, Y., Chuang, Y., Liu, C., Ho, T., Lin, Y.-S., Anderson, R., & Yeh, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-07308-3 · Cited by 86 · see citing works

A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice

Roth, C., Cantaert, T., Colas, C., Prot, M., Casadémont, I., Levillayer, L., Thalmensi, J., Langlade‐Demoyen, P., Gerke, C., Bahl, K., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01424 · Cited by 84 · see citing works

A Zika virus vaccine expressing premembrane-envelope-NS1 polyprotein

Li, A., Yu, J., Lu, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05276-4 · Cited by 79 · see citing works

An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design

Urakami, A., Tun, M. M. N., Moi, M. L., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01181-17 · Cited by 75 · see citing works

Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus

Bailey, M. J., Broecker, F., Duehr, J. E., Arumemi, F., Krammer, F., Palese, P., & Tan, G. S. (2019) · mBio · doi:10.1128/mbio.02861-18 · Cited by 71 · see citing works

DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus

da Costa, S. M., Freire, M. S., & Alves, A. M. B. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.08.022 · Cited by 61 · see citing works

Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtype

Rodrigo, W. W. S. I., Block, O. K. T., Lane, C., Sukupolvi-Petty, S., Goncalvez, A. P., Johnson, S., Diamond, M., Lai, C., Rose, R. C., Jin, X., et al. (2009) · Virology · doi:10.1016/j.virol.2009.09.024 · Cited by 55 · see citing works

ZIKV infection induces robust Th1-like Tfh cell and long-term protective antibody responses in immunocompetent mice

Liang, H., Tang, J., Liu, Z., Liu, Y., Huang, Y., Xu, Y., Hao, P., Yin, Z., Zhong, J., Ye, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11754-0 · Cited by 54 · see citing works

Licensed Dengue Vaccine: Public Health Conundrum and Scientific Challenge

Halstead, S. B. (2016) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0222 · Cited by 49 · see citing works

Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix)

Guardo, A. C., Joe, P. T., Miralles, L., Bargalló, M. E., Mothe, B., Krasniqi, A., Heirman, C., García, F., Thielemans, K., Brander, C., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001276 · Cited by 46 · see citing works

Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein

Liu, X., Qu, L., Ye, X., et al. (2018) · npj Vaccines · doi:10.1038/s41541-018-0072-6 · Cited by 43 · see citing works

Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: Their immunity and protective efficacy in mice

Lü, H., Xu, X.-F., Gao, N., et al. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.11.007 · Cited by 41 · see citing works

Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination?Preprint

Halstead, S. B. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a030700 · Cited by 41 · see citing works

A tetravalent alphavirus-vector based dengue vaccine provides effective immunity in an early life mouse model

Khalil, S. M., Tonkin, D. R., Mattocks, M. D., Snead, A. T., Johnston, R. E., & White, L. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.05.053 · Cited by 32 · see citing works

Adenovirus-Based Vaccines Generate Cytotoxic T Lymphocytes to Epitopes of NS1 from Dengue Virus That Are Present in All Major Serotypes

Gao, G., Wang, Q., Dai, Z., Calcedo, R., Sun, X., Li, G., & Wilson, J. M. (2008) · Human Gene Therapy · doi:10.1089/hum.2008.011 · Cited by 31 · see citing works

Elaboration of tetravalent antibody responses against dengue viruses using a subunit vaccine comprised of a single consensus dengue envelope sequence

Sun, J., Li, M., Wang, Y., Hao, P., & Jin, X. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.063 · Cited by 29 · see citing works

T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification

Pinto, P. B. A., Assis, M. L., Vallochi, A. L., Pacheco, A. R., Lima, L. M., Lima-Quaresma, K. R. F., Pereira, B. A. S., da Costa, S. M., & Alves, A. M. B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01522 · Cited by 25 · see citing works

Evaluation of protective efficacy using a nonstructural protein NS1 in DNA vaccine–loaded microspheres against dengue 2 virus

Yeh, M., Li, Hong, P., & Huang, S.-S. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s49972 · Cited by 20 · see citing works

Dengue researcher faces charges in vaccine fiasco

Arkin, F. (2019) · Science · doi:10.1126/science.364.6438.320 · Cited by 14 · see citing works

Establishment of Murine Infection Models with Biological Clones of Dengue Viruses Derived from a Single Clinical Viral Isolate

Zheng, Z., Li, M., Liu, Z., et al. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00229-y · Cited by 11 · see citing works

The herpes simplex virus type 1 infected cell protein 22

Lin, F., Ding, Q. J., Guo, H., & Zheng, A. C. (2010) · Virologica Sinica · doi:10.1007/s12250-010-3080-x · Cited by 10 · see citing works

Correction to: Establishment of Murine Infection Models with Biological Clones of Dengue Viruses Derived from A Single Clinical Viral Isolate

Zheng, Z., Li, M., Liu, Z., et al. (2020) · Virologica Sinica · doi:10.1007/s12250-020-00303-5 · Cited by 8 · see citing works

Both structure and function of human monoclonal antibodies contribute to enhancement of Zika virus infectivity in vitro

Li, M., Wang, X., Wang, Q., et al. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9192-0 · Cited by 6 · see citing works

Lipid nanoparticles for mRNA delivery

Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076 · see citing works

mRNA vaccines for infectious diseases: principles, delivery and clinical translation

Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555 · see citing works

Advances in COVID-19 mRNA vaccine development

Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601 · see citing works

Self-assembled mRNA vaccines

Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514 · see citing works

A Comprehensive Review of mRNA Vaccines

Gote, V., Bolla, P. K., Kommineni, N., Butreddy, A., Nukala, P. K., Palakurthi, S. S., & Khan, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032700 · Cited by 457 · see citing works

Synthetic modified messenger RNA for therapeutic applications

Gao, M., Zhang, Q., Feng, X.-H., & Liu, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.06.020 · Cited by 89 · see citing works

mRNA Vaccines against Flaviviruses

Wollner, C. J., & Richner, J. M. (2021) · Vaccines · doi:10.3390/vaccines9020148 · Cited by 44 · see citing works

A mRNA-LNP vaccine against Dengue Virus elicits robust, serotype-specific immunity

Wollner, C. J., Richner, M., Hassert, M. A., Pinto, A. K., Brien, J. D., & Richner, J. M. (2021) · doi:10.1101/2021.01.05.425517 · Cited by 6 · see citing works

DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION

Mustafa, N. H., Kelesbayev, D., & Alibekova, Z. D. (2018) · The Journal of Economic Research & Business Administration · doi:10.26577/be-2018-2-2141

Susquehanna Chorale Spring Concert "Roots and Wings"

Hawkins, D. (2017)

ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ

Атабекова, Б. Б. (2024) · Habaršy. Pedagogika ġylymdary seriâsy · doi:10.51889/2959-5762.2023.80.4.019

Genentech taps Affimed’s antibodies

Cross, R. (2018) · C&EN Global Enterprise · doi:10.1021/cen-09635-buscon15

KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK

Sari, D. (2023) · Jurnal Komplikasi Anestesi · doi:10.22146/jka.v5i1.7322